| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |